Navigation Links
Enox Biopharma, Inc. to Present at IN3 West Investment in Innovation Conference.
Date:2/22/2011

the financial burden of these infections has shifted to hospitals who are desperately seeking ways to reduce infection rates. By utilizing NO, part of the human body's innate immune system, Enox Biopharma is improving existing medical devices by making them antimicrobial.

Forward Looking Information

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on management's good faith views and expectations when made. Forward-looking statements are inherently subject to known and unknown risks and uncertainties which, in the case of the company, include raising adequate capital to continue operations, technology and product development uncertainties, and competition. Actual financial results of the company may differ, perhaps materially, from those discussed in the forward-looking statements. The company is not obligated, and does not undertake, to update its forward-looking statements or comment on the differences that may develop between its statements and actual results. Readers are encouraged to refer to the recent public filings of the company to further ascertain the risks associated with the forward-looking statements. Readers are urged not to place undue reliance upon such statements.For more information, please contact:John C. Rewcastle, Ph.D., CEO orItamar David, CFOEnoxBiopharma, Inc.604.637.9744 phone888.224.7259 faxinfo@enoxbiopharma.comwww.enoxbiopharma.com
'/>"/>

SOURCE Enox Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
2. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
3. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
4. Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
5. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Receives New Research Grant From Hong Kong Innovation and Technology Commission
6. Enox Biopharma, Inc. to Present at OneMedForum Emerging Company Finance Conference.
7. Plato BioPharma, Inc Appoints New Board Member
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
10. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... -- Research and Markets  ( http://www.researchandmarkets.com/research/rf4hfn/global ) has ... Diseases Market 2015-2019" report to their offering. ... grow at a CAGR of 4.77% over the ... present scenario and the growth prospects of the ... To calculate the market size, the report considers ...
(Date:6/3/2015)... BOSTON , June 3, 2015 PillPack, ... has completed a $50 million round of financing led ... Menlo Ventures, and Sherpa Ventures. The capital will be ... world-class team, and build retail pharmacies in US markets. ... and launched a better, simpler pharmacy experience that folks ...
(Date:6/3/2015)... June 3, 2015  Armetheon, Inc., a specialty ... cardiovascular diseases, today announced that Sanjay Kakkar ... Executive Officer, effective immediately. Dr. Kakkar brings more ... enterprises, with a successful track record in advancing ... With expertise that includes the development of novel ...
Breaking Medicine Technology:Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4
... 2007--Treatment data from,Synovate Healthcare’s European Oncology Monitor reveals ... could become eligible,for a breast cancer treatment showing ... subject of a recent study detailed,in the online ... rates were shown in patients who had switched ...
... Findings Show Survival Improvement with Lower Doses ... and other,Drugs in Newly Diagnosed Myeloma -, ... -- The,International Myeloma Foundation (IMF) - supporting ... myeloma patients,families, researchers and physicians - today ...
Cached Medicine Technology:Over 10,000 UK Breast Cancer Patients Could Become Eligible Within,the Next Year for a Breast Cancer Therapy Showing Increased,Survival Rates, Reveals Synovate Healthcare’s European,Oncology Monitor 2Over 10,000 UK Breast Cancer Patients Could Become Eligible Within,the Next Year for a Breast Cancer Therapy Showing Increased,Survival Rates, Reveals Synovate Healthcare’s European,Oncology Monitor 3The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 2The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 3
(Date:6/3/2015)... Baltimore, MD (PRWEB) June 03, 2015 On ... be a $13 billion industry by 2020 ( click here ... and Markets), computer scientists believe Baltimore has the ... fast-growing industry in which genetic code and other biological data ... and cure disease. “Baltimore contains all the elements of ...
(Date:6/3/2015)... Alberto Grignolo, PhD, will be honored ... Meeting. DIA’s Global Inspire Award program recognizes the organization’s ... commitment to service on a global scale. ... annually recognizes one DIA member for meritorious service through ... DIA to foster innovation to improve health and well-being ...
(Date:6/3/2015)... CT (PRWEB) June 03, 2015 Z-Medica®, ... announces today since June has been designated as National ... commends the Tucson, AZ. Police Department for its commitment ... its personnel utilized their Individual First Aid Kits (IFAK) ... civilians involved in shootings, stabbings or traffic accidents. Each ...
(Date:6/3/2015)... 03, 2015 Sitting at a computer ... in the back, neck, shoulders and/or wrists. This can ... In addition, recent research links sitting for long periods ... diseases. Fortunately, three inventors from Oakville, Ontario, are offering ... desk. , They have developed a prototype for a ...
(Date:6/3/2015)... Implant design can have a profound ... unites bone to an implant surface. The unique triangular-shape ... to encourage bone regeneration, resulting in the gain of ... soft tissues for more esthetic restorations. , “It’s all ... MIS Implants. The triangular neck of the V3 provides ...
Breaking Medicine News(10 mins):Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:MIS Implants Launches Radically New V3 Dental Implant For Immediate Biological Benefits 2
... Glucotrace (Fluorodeoxyglucose) for Use in Earlier, ... FLEURUS, Belgium, May 28 /PRNewswire-FirstCall/ - MDS Nordion, ... radiopharmaceuticals used in molecular medicine, today announced the ... the production of Glucotrace (Fluorodeoxyglucose), a radiopharmaceutical used ...
... results beyond soothing of infants, , , WEDNESDAY, May 27 ... and encourage feeding in premature infants, University of Alberta ... neonatal units across North America, but how beneficial it ... Dr. Manoj Kumar, an assistant clinical professor in the ...
... The Lance Armstrong Foundation (LAF) and Penn ... develop and disseminate the LIVESTRONG Care Plan Powered ... cancer survivors, their families and physicians the ability ... up-to-date treatment information based on Institute of Medicine ...
... HARRISBURG, Pa., May 27 Secretary of Public Welfare ... Smart Pharmacy initiative, saying the plan would save taxpayers ... the pharmacy initiative for providers. "The savings from the ... Richman. "This is not a drill. Pennsylvania is facing ...
... ROCHESTER, Minn. -- Researchers have discovered a novel molecular path ... that mainly affects women and slowly destroys their livers. Primary ... because it is a first step toward developing a targeted ... 11, 2009, issue of the New England Journal ...
... co-sponsored by W.K. Kellogg Foundation WASHINGTON, May 27 ... Friedman School of Nutrition Science & Policy will present ... on the most pressing nutrition and health policy issues ... join academic, corporate and government colleagues for an in-depth ...
Cached Medicine News:Health News:MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium 2Health News:Music May Temper Pain in Preemies 2Health News:Music May Temper Pain in Preemies 3Health News:LIVESTRONG and Penn Medicine announce partnership to bring online care plan tool to cancer survivors 2Health News:Secretary of Public Welfare Corrects the Record on 'Smart Pharmacy' Initiative 2Health News:Mayo researchers help discover genetic cause for primary biliary cirrhosis 2Health News:Mayo researchers help discover genetic cause for primary biliary cirrhosis 3Health News:Tufts University Friedman School of Nutrition Presents National Forum: 'Children's Health: The Future of Food & Nutrition Policy' 2
Fortitude as a unique complement to the spinal concepts family of products....
... implant made of radiolucent carbon fiber ... has a modulus of elasticity approximating ... is an implant that meets the ... while optimizing the fusion environment through ...
... Spinal Implant system. Material that has a ... bone. The result is an implant that ... support, while optimizing the fusion environment through ... anatomic design with 5 and 10 degrees ...
Caspar cervical retractor (lamina spreader), counter-retractor complete with 5 blades and forceps. Height: max. 165 mm, Maximal spread: 85 mm...
Medicine Products: